Commercial insight into the pharma and biotech sector.
M&A Activity
EvaluatePharma®’s M&A database offers unique insights into the history of the pharmaceutical industry with nearly 1,500 M&A deals valued at over $1.5 trillion.
With EvaluatePharma® you can quickly and easily evaluate the commercial success of a company’s M&A activity and track the progress of products post acquisition:
- Analyze the full M&A history for all companies
- Track M&A deals by therapy area focus and phase of compounds
- Run reports on M&A deals based on target company’s location, classification and status
- Monitor the most recent M&A activity via Peer Group Analyzer
- Evaluate industry deal values and counts for each year
- View reports on M&A activity last 3 months, pharma M&A activity Top 5 deals each year and more
- Get the latest M&A news with NewsManager plus expert comment and analysis from
EP Vantage
- All reports can be edited and customized for download to Excel, Word and PDF for sharing with colleagues
Register for access to a selection of free analysis and insights